Annapolis dermatology company Alphyn Biologics raises $3.3M, plans $17.5M round
September 27, 2022 at 14:56 PM EDT
Alphyn Biologics is planning on using its new funding for a clinical trial for its new eczema treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|